think
lab
Influencers
About
Join
3
Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trials Evaluating Setmelanotide in POMC and LEPR Deficiency Obesities
GlobeNewswire News Room
125d
1 tweets
Benjamin Voight
125d ago
I mean, I'm not surprised (given the target, MC4R), but holy christ the data for Setmelanotide looks really really promising.
0